U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Inactive Ingredients in Approved Drug Products Search

Inactive Ingredient Search for Approved Drug Products

Search Names Beginning with K

Inactive Ingredient Route Dosage Form CAS Number UNII Maximum Potency per unit dose Maximum Daily Exposure (MDE) Record Updated
KAOLIN ORAL CAPSULE 1332587 24H4NWX5CO NA
KAOLIN ORAL CAPSULE, COATED PELLETS 1332587 24H4NWX5CO 234mg
KAOLIN ORAL CAPSULE, DELAYED RELEASE PELLETS 1332587 24H4NWX5CO 234mg
KAOLIN ORAL CAPSULE, EXTENDED RELEASE 1332587 24H4NWX5CO 21mg
KAOLIN ORAL POWDER, FOR SUSPENSION 1332587 24H4NWX5CO NA
KAOLIN ORAL SYRUP 1332587 24H4NWX5CO 10mg/1ml
KAOLIN ORAL TABLET 1332587 24H4NWX5CO 150mg
KAOLIN ORAL TABLET, COATED 1332587 24H4NWX5CO 52.44mg
KAOLIN ORAL TABLET, DELAYED RELEASE 1332587 24H4NWX5CO 18.5mg
KAOLIN ORAL TABLET, EXTENDED RELEASE 1332587 24H4NWX5CO 66mg
KAOLIN ORAL TABLET, SUGAR COATED 1332587 24H4NWX5CO NA
KAOLIN TOPICAL POWDER 1332587 24H4NWX5CO 10056mg
KAOLIN TOPICAL SYSTEM 1332587 24H4NWX5CO 420mg
KARAYA GUM BUCCAL FILM, EXTENDED RELEASE 9000366 73W9IQY50Q 58mg
KOLLICOAT SR 30D ORAL SUSPENSION, EXTENDED RELEASE 9003207 IDP0HWP8PJ 186mg
KOLLICOAT SR 30D ORAL TABLET, EXTENDED RELEASE 9003207 IDP0HWP8PJ 480mg
KOLLICOAT SR 30D ORAL TABLET, FILM COATED, EXTENDED RELEASE 9003207 IDP0HWP8PJ 22.28mg
KOLLIDON SR ORAL TABLET, EXTENDED RELEASE 264876688 S34RY76LK6 564mg

 

 

FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Office of Bioequivalence
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: December 2, 2025
Database Last Updated: January 14, 2026

Back to Top